Stifel Downgrades Sarepta Therapeutic (SRPT) to Hold
Tweet
Share
E-mailGet Alerts SRPT Hot Sheet
Price: $19.46 +2.85%
Rating Summary:
19 Buy, 18 Hold, 6 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 20 | New: 18
Rating Summary:
19 Buy, 18 Hold, 6 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 20 | New: 18
Join SI Premium – FREE
Stifel downgraded Sarepta Therapeutic (NASDAQ: SRPT) from Buy to Hold and removed its price target (prior $46).
For an analyst ratings summary and ratings history on Sarepta Therapeutic click here. For more ratings news on Sarepta Therapeutic click here.
Shares of Sarepta Therapeutic closed at $23.56 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Morgan Stanley Downgrades Qifu Technology (QFIN) to Equalweight
- Nomura/Instinet Downgrades Nantong Jianghai Capacitor (002484:CH) to Neutral
- Deutsche Bank Downgrades Regions Financial (RF) to Hold
Create E-mail Alert Related Categories
DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
